You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, October 2018
|
DOI | 10.1186/s13023-018-0934-z |
Pubmed ID | |
Authors |
Jennifer Hammer, Emmanuel Seront, Steven Duez, Sophie Dupont, An Van Damme, Sandra Schmitz, Claire Hoyoux, Caroline Chopinet, Philippe Clapuyt, Frank Hammer, Miikka Vikkula, Laurence M. Boon |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 116 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 12% |
Other | 11 | 9% |
Student > Master | 11 | 9% |
Student > Bachelor | 9 | 8% |
Student > Postgraduate | 7 | 6% |
Other | 23 | 20% |
Unknown | 41 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 40 | 34% |
Biochemistry, Genetics and Molecular Biology | 9 | 8% |
Agricultural and Biological Sciences | 6 | 5% |
Nursing and Health Professions | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 9 | 8% |
Unknown | 45 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2023.
All research outputs
#3,071,217
of 23,981,346 outputs
Outputs from Orphanet Journal of Rare Diseases
#434
of 2,773 outputs
Outputs of similar age
#64,345
of 354,138 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#6
of 48 outputs
Altmetric has tracked 23,981,346 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,773 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.